South Texas Accelerated Research Therapeutics | START Madrid - CIOCC

Research site
Calle Oña 10, Planta 3 Hospital Universitario HM Sanchinarro, Madrid, Madrid, Spain
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


1 of 2
Status: Active
Trial type: Interventional
Funder type: Industry

A Study of TAS-120 in Patients With Metastatic Breast Cancer

The purpose of the trial is to evaluate a patient's response to a Fibroblast Growth Factor Receptor (FGFR) inhibitor, futibatinib (TAS-120), used eit...

Active, not recruiting
FGFR 1 High Amplification
FGFR2 Amplification
Drug: Futibatinib
Drug: Futibatinib plus Fulvestrant

Trial conditions

Breast Cancer (1 trial)
Cancer (1 trial)

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems